{"entity":{"type":"insider","cik":"0001752461","url":"/insider/0001752461","json_url":"/insider/0001752461.json","name":"Meisner Derek M","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":27,"n_filings":17,"first":"2020-09-10","last":"2026-03-10","span_basis":"filed_date"},"name_variants":[{"name":"Meisner Derek M","source":"filing","n_filings":17,"first_seen":"2020-09-10","last_seen":"2026-03-10"}],"transactions":[{"id":6040280,"accession":"0001628280-26-016645","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001628280-26-016645","line_url":"/filing/0001628280-26-016645#line-2","is_derivative":false,"issuer_cik":"0001576885","issuer_name":"Acumen Pharmaceuticals, Inc.","issuer_ticker":"ABOS","issuer_name_source":null,"issuer_url":"/issuer/0001576885","owner_cik":"0001752461","owner_name":"Meisner Derek M","owner_display_name":"Meisner Derek M","owner_url":"/insider/0001752461","role":"Officer (Chief Legal Officer & Corp Sec)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer & Corp Sec)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer & Corp Sec","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2090.0,"shares_display":"2,090","price_per_share":3.26,"price_display":"3.26","price_state":"stated","total_value":6813.4,"total_display":"6,813.40","total_whole":"6,813","shares_owned_after":173999.0,"shares_owned_after_display":"173,999","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-06","filed_date":"2026-03-10","scope":"insider"},{"id":5827271,"accession":"0001628280-26-014365","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001628280-26-014365","line_url":"/filing/0001628280-26-014365#line-2","is_derivative":false,"issuer_cik":"0001576885","issuer_name":"Acumen Pharmaceuticals, Inc.","issuer_ticker":"ABOS","issuer_name_source":null,"issuer_url":"/issuer/0001576885","owner_cik":"0001752461","owner_name":"Meisner Derek M","owner_display_name":"Meisner Derek M","owner_url":"/insider/0001752461","role":"Officer (Chief Legal Officer & Corp Sec)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer & Corp Sec)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer & Corp Sec","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9406.0,"shares_display":"9,406","price_per_share":3.0099,"price_display":"3.01","price_state":"stated","total_value":28311.1194,"total_display":"28,311.12","total_whole":"28,311","shares_owned_after":173999.0,"shares_owned_after_display":"173,999","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-27","filed_date":"2026-03-03","scope":"insider"},{"id":5802064,"accession":"0001628280-26-003948","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001628280-26-003948","line_url":"/filing/0001628280-26-003948#line-4","is_derivative":false,"issuer_cik":"0001576885","issuer_name":"Acumen Pharmaceuticals, Inc.","issuer_ticker":"ABOS","issuer_name_source":null,"issuer_url":"/issuer/0001576885","owner_cik":"0001752461","owner_name":"Meisner Derek M","owner_display_name":"Meisner Derek M","owner_url":"/insider/0001752461","role":"Officer (Chief Legal Officer & Corp Sec)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer & Corp Sec)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer & Corp Sec","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2671.0,"shares_display":"2,671","price_per_share":3.0016,"price_display":"3.00","price_state":"stated","total_value":8017.2736,"total_display":"8,017.27","total_whole":"8,017","shares_owned_after":173999.0,"shares_owned_after_display":"173,999","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-28","filed_date":"2026-01-28","scope":"insider"},{"id":5802061,"accession":"0001628280-26-003948","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001628280-26-003948","line_url":"/filing/0001628280-26-003948#line-2","is_derivative":false,"issuer_cik":"0001576885","issuer_name":"Acumen Pharmaceuticals, Inc.","issuer_ticker":"ABOS","issuer_name_source":null,"issuer_url":"/issuer/0001576885","owner_cik":"0001752461","owner_name":"Meisner Derek M","owner_display_name":"Meisner Derek M","owner_url":"/insider/0001752461","role":"Officer (Chief Legal Officer & Corp Sec)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer & Corp Sec)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer & Corp Sec","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15085.0,"shares_display":"15,085","price_per_share":3.0005,"price_display":"3.00","price_state":"stated","total_value":45262.5425,"total_display":"45,262.54","total_whole":"45,263","shares_owned_after":173999.0,"shares_owned_after_display":"173,999","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-26","filed_date":"2026-01-28","scope":"insider"},{"id":5835347,"accession":"0001628280-26-003349","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001628280-26-003349","line_url":"/filing/0001628280-26-003349#line-3","is_derivative":false,"issuer_cik":"0001576885","issuer_name":"Acumen Pharmaceuticals, Inc.","issuer_ticker":"ABOS","issuer_name_source":null,"issuer_url":"/issuer/0001576885","owner_cik":"0001752461","owner_name":"Meisner Derek M","owner_display_name":"Meisner Derek M","owner_url":"/insider/0001752461","role":"Officer (Chief Legal Officer & Corp Sec)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer & Corp Sec)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer & Corp Sec","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5633.0,"shares_display":"5,633","price_per_share":1.9027,"price_display":"1.90","price_state":"stated","total_value":10717.9091,"total_display":"10,717.91","total_whole":"10,718","shares_owned_after":173999.0,"shares_owned_after_display":"173,999","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-23","filed_date":"2026-01-23","scope":"insider"},{"id":5835345,"accession":"0001628280-26-003349","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001628280-26-003349","line_url":"/filing/0001628280-26-003349#line-2","is_derivative":false,"issuer_cik":"0001576885","issuer_name":"Acumen Pharmaceuticals, Inc.","issuer_ticker":"ABOS","issuer_name_source":null,"issuer_url":"/issuer/0001576885","owner_cik":"0001752461","owner_name":"Meisner Derek M","owner_display_name":"Meisner Derek M","owner_url":"/insider/0001752461","role":"Officer (Chief Legal Officer & Corp Sec)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer & Corp Sec)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer & Corp Sec","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1054.0,"shares_display":"1,054","price_per_share":1.84,"price_display":"1.84","price_state":"stated","total_value":1939.36,"total_display":"1,939.36","total_whole":"1,939","shares_owned_after":179632.0,"shares_owned_after_display":"179,632","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-22","filed_date":"2026-01-23","scope":"insider"},{"id":5835343,"accession":"0001628280-26-003349","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-26-003349","line_url":"/filing/0001628280-26-003349#line-1","is_derivative":false,"issuer_cik":"0001576885","issuer_name":"Acumen Pharmaceuticals, Inc.","issuer_ticker":"ABOS","issuer_name_source":null,"issuer_url":"/issuer/0001576885","owner_cik":"0001752461","owner_name":"Meisner Derek M","owner_display_name":"Meisner Derek M","owner_url":"/insider/0001752461","role":"Officer (Chief Legal Officer & Corp Sec)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer & Corp Sec)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer & Corp Sec","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2247.0,"shares_display":"2,247","price_per_share":1.8083,"price_display":"1.81","price_state":"stated","total_value":4063.2501,"total_display":"4,063.25","total_whole":"4,063","shares_owned_after":180686.0,"shares_owned_after_display":"180,686","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-21","filed_date":"2026-01-23","scope":"insider"},{"id":5872227,"accession":"0001628280-26-001896","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001628280-26-001896","line_url":"/filing/0001628280-26-001896#line-4","is_derivative":false,"issuer_cik":"0001576885","issuer_name":"Acumen Pharmaceuticals, Inc.","issuer_ticker":"ABOS","issuer_name_source":null,"issuer_url":"/issuer/0001576885","owner_cik":"0001752461","owner_name":"Meisner Derek M","owner_display_name":"Meisner Derek M","owner_url":"/insider/0001752461","role":"Officer (Chief Legal Officer & Corp Sec)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer & Corp Sec)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer & Corp Sec","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8548.0,"shares_display":"8,548","price_per_share":1.7148,"price_display":"1.71","price_state":"stated","total_value":14658.1104,"total_display":"14,658.11","total_whole":"14,658","shares_owned_after":83800.0,"shares_owned_after_display":"83,800","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-12","filed_date":"2026-01-12","scope":"insider"},{"id":5872226,"accession":"0001628280-26-001896","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001628280-26-001896","line_url":"/filing/0001628280-26-001896#line-3","is_derivative":false,"issuer_cik":"0001576885","issuer_name":"Acumen Pharmaceuticals, Inc.","issuer_ticker":"ABOS","issuer_name_source":null,"issuer_url":"/issuer/0001576885","owner_cik":"0001752461","owner_name":"Meisner Derek M","owner_display_name":"Meisner Derek M","owner_url":"/insider/0001752461","role":"Officer (Chief Legal Officer & Corp Sec)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer & Corp Sec)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer & Corp Sec","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5200.0,"shares_display":"5,200","price_per_share":1.7633,"price_display":"1.76","price_state":"stated","total_value":9169.16,"total_display":"9,169.16","total_whole":"9,169","shares_owned_after":92348.0,"shares_owned_after_display":"92,348","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-09","filed_date":"2026-01-12","scope":"insider"},{"id":5872223,"accession":"0001628280-26-001896","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001628280-26-001896","line_url":"/filing/0001628280-26-001896","is_derivative":false,"issuer_cik":"0001576885","issuer_name":"Acumen Pharmaceuticals, Inc.","issuer_ticker":"ABOS","issuer_name_source":null,"issuer_url":"/issuer/0001576885","owner_cik":"0001752461","owner_name":"Meisner Derek M","owner_display_name":"Meisner Derek M","owner_url":"/insider/0001752461","role":"Officer (Chief Legal Officer & Corp Sec)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer & Corp Sec)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer & Corp Sec","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":36911.0,"shares_display":"36,911","price_per_share":1.821840540760207,"price_display":"1.82","price_state":"stated","total_value":67245.9562,"total_display":"67,245.96","total_whole":"67,246","shares_owned_after":97548.0,"shares_owned_after_display":"97,548","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-08","filed_date":"2026-01-12","scope":"insider","n_lines":2},{"id":5995599,"accession":"0001628280-26-001262","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001628280-26-001262","line_url":"/filing/0001628280-26-001262","is_derivative":false,"issuer_cik":"0001576885","issuer_name":"Acumen Pharmaceuticals, Inc.","issuer_ticker":"ABOS","issuer_name_source":null,"issuer_url":"/issuer/0001576885","owner_cik":"0001752461","owner_name":"Meisner Derek M","owner_display_name":"Meisner Derek M","owner_url":"/insider/0001752461","role":"Officer (Chief Legal Officer & Corp Sec)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer & Corp Sec)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer & Corp Sec","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11770.0,"shares_display":"11,770","price_per_share":1.9893111299915038,"price_display":"1.99","price_state":"stated","total_value":23414.192,"total_display":"23,414.19","total_whole":"23,414","shares_owned_after":134459.0,"shares_owned_after_display":"134,459","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-07","filed_date":"2026-01-07","scope":"insider","n_lines":2},{"id":5995593,"accession":"0001628280-26-001262","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001628280-26-001262","line_url":"/filing/0001628280-26-001262","is_derivative":false,"issuer_cik":"0001576885","issuer_name":"Acumen Pharmaceuticals, Inc.","issuer_ticker":"ABOS","issuer_name_source":null,"issuer_url":"/issuer/0001576885","owner_cik":"0001752461","owner_name":"Meisner Derek M","owner_display_name":"Meisner Derek M","owner_url":"/insider/0001752461","role":"Officer (Chief Legal Officer & Corp Sec)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer & Corp Sec)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer & Corp Sec","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10898.0,"shares_display":"10,898","price_per_share":1.9671302440814828,"price_display":"1.97","price_state":"stated","total_value":21437.7854,"total_display":"21,437.79","total_whole":"21,438","shares_owned_after":150030.0,"shares_owned_after_display":"150,030","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-06","filed_date":"2026-01-07","scope":"insider","n_lines":2},{"id":5995587,"accession":"0001628280-26-001262","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-26-001262","line_url":"/filing/0001628280-26-001262#line-1","is_derivative":false,"issuer_cik":"0001576885","issuer_name":"Acumen Pharmaceuticals, Inc.","issuer_ticker":"ABOS","issuer_name_source":null,"issuer_url":"/issuer/0001576885","owner_cik":"0001752461","owner_name":"Meisner Derek M","owner_display_name":"Meisner Derek M","owner_url":"/insider/0001752461","role":"Officer (Chief Legal Officer & Corp Sec)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer & Corp Sec)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer & Corp Sec","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":1.9595,"price_display":"1.96","price_state":"stated","total_value":7838.0,"total_display":"7,838.00","total_whole":"7,838","shares_owned_after":157127.0,"shares_owned_after_display":"157,127","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-05","filed_date":"2026-01-07","scope":"insider"},{"id":5217518,"accession":"0001576885-25-000033","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001576885-25-000033","line_url":"/filing/0001576885-25-000033#line-1","is_derivative":false,"issuer_cik":"0001576885","issuer_name":"Acumen Pharmaceuticals, Inc.","issuer_ticker":"ABOS","issuer_name_source":null,"issuer_url":"/issuer/0001576885","owner_cik":"0001752461","owner_name":"Meisner Derek M","owner_display_name":"Meisner Derek M","owner_url":"/insider/0001752461","role":"Officer (Chief Legal Officer & Corp Sec)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer & Corp Sec)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer & Corp Sec","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3418.0,"shares_display":"3,418","price_per_share":1.59,"price_display":"1.59","price_state":"stated","total_value":5434.62,"total_display":"5,434.62","total_whole":"5,435","shares_owned_after":161127.0,"shares_owned_after_display":"161,127","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-21","filed_date":"2025-01-23","scope":"insider"},{"id":4402790,"accession":"0001576885-25-000015","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001576885-25-000015","line_url":"/filing/0001576885-25-000015#line-1","is_derivative":false,"issuer_cik":"0001576885","issuer_name":"Acumen Pharmaceuticals, Inc.","issuer_ticker":"ABOS","issuer_name_source":null,"issuer_url":"/issuer/0001576885","owner_cik":"0001752461","owner_name":"Meisner Derek M","owner_display_name":"Meisner Derek M","owner_url":"/insider/0001752461","role":"Officer (Chief Legal Officer & Corp Sec)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer & Corp Sec)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer & Corp Sec","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11122.0,"shares_display":"11,122","price_per_share":1.8437,"price_display":"1.84","price_state":"stated","total_value":20505.6314,"total_display":"20,505.63","total_whole":"20,506","shares_owned_after":97745.0,"shares_owned_after_display":"97,745","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-03","filed_date":"2025-01-07","scope":"insider"},{"id":2114460,"accession":"0001576885-24-000027","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001576885-24-000027","line_url":"/filing/0001576885-24-000027#line-1","is_derivative":false,"issuer_cik":"0001576885","issuer_name":"Acumen Pharmaceuticals, Inc.","issuer_ticker":"ABOS","issuer_name_source":null,"issuer_url":"/issuer/0001576885","owner_cik":"0001752461","owner_name":"Meisner Derek M","owner_display_name":"Meisner Derek M","owner_url":"/insider/0001752461","role":"Officer (Chief Legal Officer & Corp Sec)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer & Corp Sec)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer & Corp Sec","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8933.0,"shares_display":"8,933","price_per_share":3.4757,"price_display":"3.48","price_state":"stated","total_value":31048.4281,"total_display":"31,048.43","total_whole":"31,048","shares_owned_after":108867.0,"shares_owned_after_display":"108,867","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-19","filed_date":"2024-01-19","scope":"insider"},{"id":6135243,"accession":"0001628280-22-023326","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-22-023326","line_url":"/filing/0001628280-22-023326#line-1","is_derivative":false,"issuer_cik":"0001501697","issuer_name":"X4 Pharmaceuticals, Inc","issuer_ticker":"XFOR","issuer_name_source":null,"issuer_url":"/issuer/0001501697","owner_cik":"0001752461","owner_name":"Meisner Derek M","owner_display_name":"Meisner Derek M","owner_url":"/insider/0001752461","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8334.0,"shares_display":"8,334","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":145155.0,"shares_owned_after_display":"145,155","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-17","filed_date":"2022-08-19","scope":"insider"},{"id":6732998,"accession":"0001628280-22-018042","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-22-018042","line_url":"/filing/0001628280-22-018042#line-1","is_derivative":false,"issuer_cik":"0001501697","issuer_name":"X4 Pharmaceuticals, Inc","issuer_ticker":"XFOR","issuer_name_source":null,"issuer_url":"/issuer/0001501697","owner_cik":"0001752461","owner_name":"Meisner Derek M","owner_display_name":"Meisner Derek M","owner_url":"/insider/0001752461","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4166.0,"shares_display":"4,166","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":153489.0,"shares_owned_after_display":"153,489","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-24","filed_date":"2022-06-27","scope":"insider"},{"id":6499401,"accession":"0001628280-22-017433","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-22-017433","line_url":"/filing/0001628280-22-017433#line-1","is_derivative":false,"issuer_cik":"0001501697","issuer_name":"X4 Pharmaceuticals, Inc","issuer_ticker":"XFOR","issuer_name_source":null,"issuer_url":"/issuer/0001501697","owner_cik":"0001752461","owner_name":"Meisner Derek M","owner_display_name":"Meisner Derek M","owner_url":"/insider/0001752461","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4166.0,"shares_display":"4,166","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":157655.0,"shares_owned_after_display":"157,655","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-16","filed_date":"2022-06-17","scope":"insider"},{"id":6435248,"accession":"0001628280-22-002509","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-22-002509","line_url":"/filing/0001628280-22-002509#line-1","is_derivative":false,"issuer_cik":"0001501697","issuer_name":"X4 Pharmaceuticals, Inc","issuer_ticker":"XFOR","issuer_name_source":null,"issuer_url":"/issuer/0001501697","owner_cik":"0001752461","owner_name":"Meisner Derek M","owner_display_name":"Meisner Derek M","owner_url":"/insider/0001752461","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15909.0,"shares_display":"15,909","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":56821.0,"shares_owned_after_display":"56,821","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-11","filed_date":"2022-02-14","scope":"insider"},{"id":4490212,"accession":"0001628280-21-017332","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-21-017332","line_url":"/filing/0001628280-21-017332#line-1","is_derivative":false,"issuer_cik":"0001501697","issuer_name":"X4 Pharmaceuticals, Inc","issuer_ticker":"XFOR","issuer_name_source":null,"issuer_url":"/issuer/0001501697","owner_cik":"0001752461","owner_name":"Meisner Derek M","owner_display_name":"Meisner Derek M","owner_url":"/insider/0001752461","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8332.0,"shares_display":"8,332","price_per_share":5.1,"price_display":"5.10","price_state":"stated","total_value":42493.2,"total_display":"42,493.20","total_whole":"42,493","shares_owned_after":72730.0,"shares_owned_after_display":"72,730","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-17","filed_date":"2021-08-19","scope":"insider"},{"id":5079260,"accession":"0001628280-21-012932","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001628280-21-012932","line_url":"/filing/0001628280-21-012932#line-2","is_derivative":false,"issuer_cik":"0001501697","issuer_name":"X4 Pharmaceuticals, Inc","issuer_ticker":"XFOR","issuer_name_source":null,"issuer_url":"/issuer/0001501697","owner_cik":"0001752461","owner_name":"Meisner Derek M","owner_display_name":"Meisner Derek M","owner_url":"/insider/0001752461","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4166.0,"shares_display":"4,166","price_per_share":7.0,"price_display":"7.00","price_state":"stated","total_value":29162.0,"total_display":"29,162.00","total_whole":"29,162","shares_owned_after":81062.0,"shares_owned_after_display":"81,062","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-24","filed_date":"2021-06-25","scope":"insider"},{"id":5473020,"accession":"0001628280-21-012478","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001628280-21-012478","line_url":"/filing/0001628280-21-012478#line-2","is_derivative":false,"issuer_cik":"0001501697","issuer_name":"X4 Pharmaceuticals, Inc","issuer_ticker":"XFOR","issuer_name_source":null,"issuer_url":"/issuer/0001501697","owner_cik":"0001752461","owner_name":"Meisner Derek M","owner_display_name":"Meisner Derek M","owner_url":"/insider/0001752461","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4166.0,"shares_display":"4,166","price_per_share":7.84,"price_display":"7.84","price_state":"stated","total_value":32661.44,"total_display":"32,661.44","total_whole":"32,661","shares_owned_after":72728.0,"shares_owned_after_display":"72,728","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-15","filed_date":"2021-06-17","scope":"insider"},{"id":2320465,"accession":"0001628280-20-013419","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-20-013419","line_url":"/filing/0001628280-20-013419#line-1","is_derivative":false,"issuer_cik":"0001501697","issuer_name":"X4 Pharmaceuticals, Inc","issuer_ticker":"XFOR","issuer_name_source":null,"issuer_url":"/issuer/0001501697","owner_cik":"0001752461","owner_name":"Meisner Derek M","owner_display_name":"Meisner Derek M","owner_url":"/insider/0001752461","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8334.0,"shares_display":"8,334","price_per_share":8.05,"price_display":"8.05","price_state":"stated","total_value":67088.7,"total_display":"67,088.70","total_whole":"67,089","shares_owned_after":16666.0,"shares_owned_after_display":"16,666","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-09-09","filed_date":"2020-09-10","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":27,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":27,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":27},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001576885","name":"Acumen Pharmaceuticals, Inc.","url":"/issuer/0001576885","role":"Officer (Chief Legal Officer & Corp Sec)","n_filings":9,"first_seen":"2024-01-19","last_seen":"2026-03-10"},{"type":"issuer","type_label":"ISSUER","cik":"0001501697","name":"X4 Pharmaceuticals, Inc","url":"/issuer/0001501697","role":"Officer (Chief Legal Officer)","n_filings":8,"first_seen":"2020-09-10","last_seen":"2022-08-19"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001752461","retrieved_at":"2026-08-26T15:02:53+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}